Table of Contents

company-logo

Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein. The company's NELL-1/DBX is a combination product, which is an osteostimulative recombinant protein that provides target specific control over bone regeneration. It is developing NELL-1/DBX Fusion Device for spinal fusion procedures in skeletally mature patients with degenerative disc disease at one level from L4-S1. The company's platform technology has application in delivering enhanced outcomes in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine. It has a license agreement with the UCLA Technology Development Group to develop and commercialize NELL-1 for spinal fusion applications. The company was founded in 2004 and is headquartered in Burlington, Massachusetts.

Bone Biologics Dividend Announcement

• Bone Biologics does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on Bone Biologics dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

Bone Biologics Dividend History

Bone Biologics Dividend Yield

Bone Biologics current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Bone Biologics stock? Use our calculator to estimate your expected dividend yield:

Bone Biologics Financial Ratios

P/E ratio-0.54
PEG ratio0.03
P/B ratio0.59
ROE-124.69%
Payout ratio0.00%
Current ratio14.87
Quick ratio14.87
Cash Ratio13.04

Bone Biologics Dividend FAQ

Does Bone Biologics stock pay dividends?
Bone Biologics does not currently pay dividends to its shareholders.
Has Bone Biologics ever paid a dividend?
No, Bone Biologics has no a history of paying dividends to its shareholders. Bone Biologics is not known for its dividend payments.
Why doesn't Bone Biologics pay dividends?
There are several potential reasons why Bone Biologics would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Bone Biologics ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Bone Biologics has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Bone Biologics a dividend aristocrat?
Bone Biologics is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Bone Biologics a dividend king?
Bone Biologics is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Bone Biologics a dividend stock?
No, Bone Biologics is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Bone Biologics stocks?
To buy Bone Biologics you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Bone Biologics stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.